Zhimin Shao

Zhimin Shao

UNVERIFIED PROFILE

Are you Zhimin Shao?   Register this Author

Register author
Zhimin Shao

Zhimin Shao

Publications by authors named "Zhimin Shao"

Are you Zhimin Shao?   Register this Author

100Publications

2634Reads

30Profile Views

Internal mammary node irradiation improves 8-year survival in breast cancer patients: results from a retrospective cohort study in real-world setting.

Breast Cancer 2019 Nov 6. Epub 2019 Nov 6.

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 DongAn Road, Shanghai, 200032, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-019-01015-9DOI Listing
November 2019

Current practice and barriers of mesh-assisted implant-based breast reconstruction in China: A nationwide cross-sectional survey of 110 hospitals.

Eur J Surg Oncol 2019 Sep 5. Epub 2019 Sep 5.

Department of Breast Surgery, Fudan University Shanghai Cancer Center, No. 270, Dongan Rd., Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, China; Collaborative Innovation Center for Cancer Medicine, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejso.2019.09.001DOI Listing
September 2019

Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis.

Cancer Chemother Pharmacol 2019 Aug 27;84(2):373-382. Epub 2019 May 27.

Institut de Recherche Pierre Fabre, 3 Avenue Hubert Curien, 31035, Toulouse, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-019-03872-9
Publisher Site
http://dx.doi.org/10.1007/s00280-019-03872-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647192PMC
August 2019

LINC00309 is associated with short disease-free survival in breast cancer.

Cancer Cell Int 2019 7;19:210. Epub 2019 Aug 7.

1Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Building 2, No. 270 Dong An Road, Shanghai, 200032 China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12935-019-0887-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686222PMC
August 2019

Comparison of 4th ESO-ESMO international consensus guidelines for advance breast cancer and Chinese anti-cancer association committee of Breast Cancer Society guideline.

Breast 2019 Jun 22;45:36-42. Epub 2019 Feb 22.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2019.02.009DOI Listing
June 2019

Fulvestrant in the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: A review.

Cancer Med 2019 May 19;8(5):1943-1957. Epub 2019 Apr 19.

Department of Surgery in Breast Cancer, Fudan University Shanghai Cancer Center, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536994PMC
May 2019

CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription.

Theranostics 2018 3;8(9):2549-2564. Epub 2018 Apr 3.

Department of Breast Surgery, Breast Cancer Institute, Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/thno.22523DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928908PMC
April 2019

The Impact of Radiotherapy on Reoperation Rates in Patients Undergoing Mastectomy and Breast Reconstruction.

Ann Surg Oncol 2019 Apr 23;26(4):961-968. Epub 2019 Jan 23.

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-018-07135-4DOI Listing
April 2019

Internal Mammary Node Irradiation (IMNI) Improves Survival Outcome for Patients With Clinical Stage II-III Breast Cancer After Preoperative Systemic Therapy.

Int J Radiat Oncol Biol Phys 2019 03 12;103(4):895-904. Epub 2018 Nov 12.

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016183395
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2018.11.003DOI Listing
March 2019

Characteristics of Mammographic Breast Density and Associated Factors for Chinese Women: Results from an Automated Measurement.

J Oncol 2019 19;2019:4910854. Epub 2019 Mar 19.

Medical Radiation Sciences, Faculty of Health Sciences, The University of Sydney, Cumberland Campus, 75 East Street, Lidcombe, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/4910854DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444251PMC
March 2019

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.

N Engl J Med 2019 02 5;380(7):617-628. Epub 2018 Dec 5.

From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie - Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of Gynecology and Obstetrics, University Hospital Erlangen, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen (P.A.F.), and Mammazentrum Hamburg am Krankenhaus Jerusalem, Hamburg (P.W.) - all in Germany; the National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan (C.-S.H.); Instituto do Câncer do Estado de São Paulo, São Paulo (M.S.M.); the National Surgical Adjuvant Breast and Bowel Project (NSABP) Foundation and Orlando Health University of Florida Health Cancer Center, Orlando (E.P.M.); the NSABP Foundation and Allegheny Health Network Cancer Institute (N.W.) and the NSABP Foundation and University of Pittsburgh Cancer Institute, School of Medicine (P.R.), Pittsburgh; Hospital Universitario La Paz-Instituto de Investigación Hospital Universitario La Paz, Madrid (A.R.); Institut Régional du Cancer de Montpellier, Université de Montpellier, INSERM Unité 1194, Montpellier, France (W.J.); the NSABP Foundation and Providence Portland Medical Center, Portland, OR (A.K.C.); the National Cancer Institute, Mexico City (C.A.-S.); the NSABP Foundation and Stanford University School of Medicine, Stanford (I.L.W.), and Genentech, South San Francisco (L.H.L., D.T., M.S., S.M.S.) - both in California; Yale University School of Medicine, Yale Cancer Center, and Smilow Cancer Hospital, New Haven, CT (M.P.D.); the Ireland Cooperative Oncology Research Group, Dublin (J.P.C.); Fudan University Shanghai Cancer Center (Z.S.) and Roche (China) Holding (H.W.), Shanghai; the Cancer Center Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy (E.R.C.); F. Hoffmann-La Roche, Welwyn Garden City, United Kingdom (H.D.); and the NSABP Foundation and Virginia Commonwealth University Massey Cancer Center, Richmond (C.E.G.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1814017
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1814017DOI Listing
February 2019

Overexpression of NIMA-related kinase 6 (NEK6) contributes to malignant growth and dismal prognosis in Human Breast Cancer.

Pathol Res Pract 2018 Oct 27;214(10):1648-1654. Epub 2018 Jul 27.

Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, PR China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.prp.2018.07.030DOI Listing
October 2018

RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients.

Cancer Cell Int 2018 25;18:170. Epub 2018 Oct 25.

1Department of Breast Surgery, Shanghai Cancer Center, Fudan University, Shanghai, 200032 People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12935-018-0658-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203216PMC
October 2018

The Preventive Intervention of Hereditary Breast Cancer.

Adv Exp Med Biol 2017 ;1026:41-57

Department of Breast Surgery, Shanghai Cancer Center/Cancer Institute, Fudan University, No.270 Dong'an Road, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-981-10-6020-5_3DOI Listing
July 2018

Mammographic density and other risk factors for breast cancer among women in China.

Breast J 2018 05 29;24(3):426-428. Epub 2017 Nov 29.

Medical Radiation Sciences, Faculty of Health Sciences, The University of Sydney, Lidcombe, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12967DOI Listing
May 2018

Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in vivo.

Mol Med Rep 2018 Apr 29;17(4):5470-5476. Epub 2018 Jan 29.

Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mmr.2018.8514DOI Listing
April 2018

Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer.

BMC Cancer 2018 04 19;18(1):446. Epub 2018 Apr 19.

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4371-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909254PMC
April 2018

Targeting deubiquitinase USP28 for cancer therapy.

Cell Death Dis 2018 02 7;9(2):186. Epub 2018 Feb 7.

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41419-017-0208-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833459PMC
February 2018

CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2.

Cancer Lett 2018 01 28;412:69-80. Epub 2017 Sep 28.

Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, 200032, China; Central Laboratory, The Fifth People's Hospital of Shanghai, Fudan University, 200240, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2017.09.030DOI Listing
January 2018

Divergent Responses of Forest Soil Microbial Communities under Elevated CO in Different Depths of Upper Soil Layers.

Appl Environ Microbiol 2018 Jan 15;84(1). Epub 2017 Dec 15.

CAS Key Laboratory of Environmental Biotechnology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences (CAS), Beijing, China

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AEM.01694-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734029PMC
January 2018

CYR61 Confers the Sensitivity to Aromatase Inhibitor Letrozole in ER Positive Breast Carcinoma.

Curr Cancer Drug Targets 2017 ;17(2):191-197

Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong-An Road, Shanghai 200032, P. R. China. Select country.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568009616666160426125058DOI Listing
October 2017

Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer.

Oncotarget 2017 Oct 16;8(45):79527-79536. Epub 2017 Jun 16.

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.18539DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668065PMC
October 2017

Breast Cancer-Specific Mortality Pattern and Its Changing Feature According to Estrogen Receptor Status in Two Time Periods.

PLoS One 2016 14;11(6):e0157322. Epub 2016 Jun 14.

Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157322PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907475PMC
July 2017

Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy.

Oncotarget 2017 Mar;8(11):18399-18408

Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.9369DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392337PMC
March 2017

Identify high risk estrogen receptor-positive breast cancer patients for extended endocrine therapy.

Breast 2017 Feb 18;31:173-180. Epub 2016 Nov 18.

Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, People's Republic of China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2016.11.008DOI Listing
February 2017

The association between China's Great famine and risk of breast cancer according to hormone receptor status: a hospital-based study.

Breast Cancer Res Treat 2016 11 1;160(2):361-369. Epub 2016 Oct 1.

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine and Siteman Cancer Center, 660 South Euclid Ave, Campus Box 8100, St Louis, MO, 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3994-6DOI Listing
November 2016

Local recurrence following mastectomy and autologous breast reconstruction: incidence, risk factors, and management.

Onco Targets Ther 2016 4;9:6829-6834. Epub 2016 Nov 4.

Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S109356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104291PMC
November 2016

The Type of Breast Reconstruction May Not Influence Patient Satisfaction in the Chinese Population: A Single Institutional Experience.

PLoS One 2015 12;10(11):e0142900. Epub 2015 Nov 12.

Department of Breast Surgery, Cancer Center/Cancer Institute, Fudan University, 270 Dong'an Road, Shanghai 200032, People's Republic of China.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0142900PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642975PMC
July 2016

Free Flap Monitoring Using Near-Infrared Spectroscopy: A Systemic Review.

Ann Plast Surg 2016 May;76(5):590-7

From the *Department of Breast Surgery, Shanghai Cancer Center, and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; and †Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/annalsplasticsurgery/2016/05000
Web Search
http://dx.doi.org/10.1097/SAP.0000000000000430DOI Listing
May 2016

Erratum to: FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.

Breast Cancer Res Treat 2016 Apr;156(3):609-610

The Institute of Genetics and Cytology, Northeast Normal University, 5268 Renmin Street, Changchun, 130024, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3772-5DOI Listing
April 2016

Epidural Combined with General Anesthesia versus General Anesthesia Alone in Patients Undergoing Free Flap Breast Reconstruction.

Plast Reconstr Surg 2016 Mar;137(3):502e-509e

Shanghai, People's Republic of China; and Houston, Texas From the Departments of Anesthesiology and Breast Surgery, Fudan University Shanghai Cancer Center, and the Department of Oncology, Shanghai Medical College, Fudan University; and the Department of Plastic Surgery, The University of Texas M. D. Anderson Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.prs.0000479933.75887.82DOI Listing
March 2016

The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.

Medicine (Baltimore) 2016 Feb;95(8):e2914

From the Departments of Radiation Oncology (JL, ZZ, ZY, XC, XG, XF, XY), Nuclear Medicine (JC), and Breast Surgery (ZS), Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University (JL, ZZ, ZY, XC, XG, XF, XY, JC, ZS), Shanghai, China; and National Cancer Centre Singapore (JT), Singapore, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000002914DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779032PMC
February 2016

Phase II study of Pseudomonas aeruginosa-Mannose-Sensitive hemagglutinin in combination with capecitabine for Her-2-negative metastatic breast cancer pretreated with anthracycline and taxane.

PLoS One 2015 13;10(3):e0118607. Epub 2015 Mar 13.

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0118607PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359133PMC
January 2016

Breast Sclerosing Adenosis and Accompanying Malignancies: A Clinicopathological and Imaging Study in a Chinese Population.

Medicine (Baltimore) 2015 Dec;94(49):e2298

From the Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China (NH, JC, JX, ZS, JW); Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China (BY, WY); Department of Diagnostic Radiology, Fudan University Shanghai Cancer Center, Shanghai, China (YC); Department of Oncology, Fudan University Shanghai Medical College, Shanghai, China (NH, JC, JX, BY, YC, WY, ZS, JW); and Collaborative Innovation Center for Cancer Medicine, Guangdong, China (JW).

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/md-journal/2015/12080/Breast_Sc
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MD.0000000000002298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008523PMC
December 2015

[Germline mutations of TP53 gene among Chinese families with high risk for breast cancer].

Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2015 Dec;32(6):761-5

Breast Cancer Institute, Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, P.R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.1003-9406.2015.06.001DOI Listing
December 2015

A phase II trial of biweekly vinorelbine and oxaliplatin in second- or third-line metastatic triple-negative breast cancer.

Cancer Biol Ther 2015 ;16(2):225-32

a Department of Medical Oncology ; Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University ; Shanghai , China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/15384047.2014.986973DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622533PMC
November 2015

Mammography screening in less developed countries.

Springerplus 2015 15;4:615. Epub 2015 Oct 15.

Department of Breast Surgery, Shanghai Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40064-015-1394-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627993PMC
November 2015

Clinical significance of locoregional and systemic treatment in operable high-risk breast cancer patients with more than four positive axillary lymph nodes.

Onco Targets Ther 2015 21;8:2665-73. Epub 2015 Sep 21.

Breast Cancer Center, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S88216DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590555PMC
October 2015

National consensus in China on diagnosis and treatment of patients with advanced breast cancer.

Ann Transl Med 2015 Oct;3(17):242

1 Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China ; 2 Cancer Hospital of Fudan University, Shanghai 200032, China ; 3 Beijing 307 Hospital of PLA, Beijing 100101, China ; 4 Cancer Hospital of Peking University, Beijing 100142, China ; 5 Ruijin Hospital of Shanghai Jiaotong University, Shanghai 200020, China ; 6 Henan Cancer Hospital, Zhengzhou 450008, China ; 7 Guangdong General Hospital, Guangzhou 510080, China ; 8 Cancer Center, Sun Yat-sen University, Guangzhou 510060, China ; 9 Fujian Cancer Hospital, Fuzhou 350000, China ; 10 Renji Hospital, Shanghai Jiaotong University, Shanghai 200032, China ; 11 Liaoning Cancer Hospital, Shenyang 110042, China ; 12 First Affiliated Hospital of China Medical University, Shenyang 110001, China ; 13 Cancer Hospital, Tianjin Medical University, Tianjin 300060, China ; 14 Zhejiang Cancer Hospital, Hangzhou 310022, China ; 15 Shandong Cancer Hospital, Jinan 250031, China ; 16 Cancer Hospital, Harbin Medical University, Harbin 150000, China ; 17 West China Hospital, Sichuan University, Chendu 610041, China ; 18 First Affiliated Hospital, Chongqing Medical University, Chongqing 400014, China ; 19 Second Affiliated Hospital, Sun Yat-sen University, Guangzhou 510175, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2305-5839.2015.09.47DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620095PMC
October 2015

Reproductive factors and hormone receptor status among very young (<35 years) breast cancer patients.

Oncotarget 2015 Sep;6(27):24571-80

Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P. R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.4698DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695207PMC
September 2015

Rosiglitazone improves learning and memory ability in rats with type 2 diabetes through the insulin signaling pathway.

Am J Med Sci 2015 Aug;350(2):121-8

Central Laboratory (LM, ZS, RW, ZZ, WD, JZ, XZ, SS, ZJ, JZ), Xuan Wu Hospital, Capital Medical University, Key Laboratory for Neurodegenerative Disease of Ministry of Education, Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing, China; and Department of Geriatrics (LM), Xuan Wu Hospital, Capital Medical University, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAJ.0000000000000499DOI Listing
August 2015

Similar prognoses for invasive micropapillary breast carcinoma and pure invasive ductal carcinoma: a retrospectively matched cohort study in China.

PLoS One 2014 4;9(9):e106564. Epub 2014 Sep 4.

Department of Breast Surgery, Fudan University Shanghai Cancer Center/Cancer Institute, Shanghai, People's Republic of China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China; Institutes of Biomedical Science, Fudan University, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0106564PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154720PMC
May 2015

Estimating cardiac substructures exposure from diverse radiotherapy techniques in treating left-sided breast cancer.

Medicine (Baltimore) 2015 May;94(18):e847

From the From the Department of Radiation Oncology (LZ, XM, XC,WH, XG, XY); Department of Nuclear Medicine (SH, YZ); Department of Breast Surgery(ZS), Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; and Department of Radiation Oncology, National Cancer Centre Singapore,Singapore, Singapore (JT).

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00005792-201505020-000
Publisher Site
http://dx.doi.org/10.1097/MD.0000000000000847DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602531PMC
May 2015

The β-amyloid precursor protein analog P165 improves impaired insulin signal transduction in type 2 diabetic rats.

Neurol Sci 2015 Apr 8;36(4):593-8. Epub 2014 Nov 8.

Central Laboratory, Xuan Wu Hospital, Capital Medical University, Key Laboratory for Neurodegenerative Disease of Ministry of Education, Beijing Geriatric Medical Research Center, Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, #45 Changchun Street, Xicheng, Beijing, 100053, China.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10072-014-1997-9
Publisher Site
http://dx.doi.org/10.1007/s10072-014-1997-9DOI Listing
April 2015

Indispensability of chemotherapy in estrogen receptor-negative early breast cancer in elderly women with diabetes mellitus.

Diabetes Technol Ther 2015 Apr;17(4):248-54

1 Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Shanghai Medical College, Fudan University , Shanghai, People's Republic of China .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/dia.2014.0226DOI Listing
April 2015

Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.

Oncotarget 2015 Apr;6(11):8648-62

Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P.R. China.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/3257
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496173PMC
http://dx.doi.org/10.18632/oncotarget.3257DOI Listing
April 2015

In-line phase-contrast and grating-based phase-contrast synchrotron imaging study of brain micrometastasis of breast cancer.

Sci Rep 2015 Mar 30;5:9418. Epub 2015 Mar 30.

Department of Breast Surgery, Breast Cancer Institute, Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/srep09418
Publisher Site
http://dx.doi.org/10.1038/srep09418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377630PMC
March 2015

Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer.

Int J Cancer 2015 Jan 23;136(1):204-11. Epub 2014 May 23.

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Xuhui District, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28966DOI Listing
January 2015

The role of mammographic calcification in the neoadjuvant therapy of breast cancer imaging evaluation.

PLoS One 2014 11;9(2):e88853. Epub 2014 Feb 11.

Department of Breast Surgery, Cancer Center and Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0088853PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921249PMC
October 2014

Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer.

Int J Nanomedicine 2014 19;9:1443-52. Epub 2014 Mar 19.

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/IJN.S58275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964033PMC
August 2014

Adjuvant chemotherapy increases the prevalence of fat necrosis in immediate free abdominal flap breast reconstruction.

J Plast Reconstr Aesthet Surg 2014 Apr 29;67(4):461-7. Epub 2014 Jan 29.

Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bjps.2014.01.008DOI Listing
April 2014

Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway.

BMC Cancer 2014 Feb 16;14:96. Epub 2014 Feb 16.

Department of Medical Oncology, Fudan University Shanghai Cancer Center, 200032 Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-96DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015735PMC
February 2014

Phosphorylated VEGFR2 and hypertension: potential biomarkers to indicate VEGF-dependency of advanced breast cancer in anti-angiogenic therapy.

Breast Cancer Res Treat 2014 Jan 1;143(1):141-51. Epub 2013 Dec 1.

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-013-2793-6
Publisher Site
http://dx.doi.org/10.1007/s10549-013-2793-6DOI Listing
January 2014

COX-2 promotes breast cancer cell radioresistance via p38/MAPK-mediated cellular anti-apoptosis and invasiveness.

Tumour Biol 2013 Oct 15;34(5):2817-26. Epub 2013 Jun 15.

Cancer Research Laboratory, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-013-0840-xDOI Listing
October 2013

Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.

Cancer 2013 Jul 10;119(13):2366-74. Epub 2013 Apr 10.

Department of Radiation Oncology, Hospital of Fudan University, Shanghai, China.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.28085
Publisher Site
http://dx.doi.org/10.1002/cncr.28085DOI Listing
July 2013

Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesis.

Clin Exp Metastasis 2013 Jun 19;30(5):671-80. Epub 2013 Mar 19.

Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, No. 138 Yixueyuan Road, Shanghai, 200032, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10585-013-9571-zDOI Listing
June 2013

An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study.

Cancer Chemother Pharmacol 2012 Feb 27;69(2):515-22. Epub 2011 Aug 27.

Department of Medical Oncology, Cancer Hospital of Fudan University, Shanghai Medical College, 270 Dongan Road, Shanghai 200032, China.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00280-011-1728
Web Search
http://link.springer.com/10.1007/s00280-011-1728-3
Publisher Site
http://dx.doi.org/10.1007/s00280-011-1728-3DOI Listing
February 2012

FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.

Breast Cancer Res Treat 2012 Jan 5;131(1):65-73. Epub 2011 Apr 5.

The Institute of Genetics and Cytology, Northeast Normal University, 5268 Renmin Street, Changchun 130024, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1396-3DOI Listing
January 2012

The efficacy of zoledronic acid in breast cancer adjuvant therapy: a meta-analysis of randomised controlled trials.

Eur J Cancer 2012 Jan 17;48(2):187-95. Epub 2011 Nov 17.

Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049110082
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2011.10.021DOI Listing
January 2012

Trastuzumab in the adjuvant treatment of HER2-positive early breast cancer patients: a meta-analysis of published randomized controlled trials.

PLoS One 2011 9;6(6):e21030. Epub 2011 Jun 9.

Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0021030PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111470PMC
October 2011

The role of topoisomerase IIα in predicting sensitivity to anthracyclines in breast cancer patients: a meta-analysis of published literatures.

Breast Cancer Res Treat 2011 Oct 2;129(3):839-48. Epub 2011 Aug 2.

Department of Breast Surgery, Shanghai Cancer Center, Fudan University, 399 Ling-Ling Road, Shanghai 200032, China.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-011-1694-9
Publisher Site
http://dx.doi.org/10.1007/s10549-011-1694-9DOI Listing
October 2011

PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib.

BMC Cancer 2011 Jun 15;11:248. Epub 2011 Jun 15.

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-11-248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141770PMC
June 2011

Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapy.

Cancer Lett 2011 Mar 8;302(1):63-8. Epub 2011 Jan 8.

Department of Breast Surgery, Fudan University Shanghai Cancer Center, 270 Dong An Road, 200032, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2010.12.014DOI Listing
March 2011

Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial.

Cancer Chemother Pharmacol 2011 Jan 12;67(1):223-30. Epub 2010 Oct 12.

Department of Medical Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, 100021 Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1483-xDOI Listing
January 2011

Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance.

Breast Cancer Res Treat 2010 Dec 30;124(3):733-43. Epub 2010 Sep 30.

Department of Medical Oncology, Fudan University Cancer Hospital, Shanghai, 200032, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-1183-6DOI Listing
December 2010

Using peripheral blood mRNA signature to distinguish between breast cancer and benign breast disease in non-conclusive mammography patients.

Cancer Biol Ther 2010 Dec 15;10(12):1235-9. Epub 2010 Dec 15.

Fudan University Shanghai Cancer Center, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.10.12.13437DOI Listing
December 2010

External qigong therapy for women with breast cancer prior to surgery.

Integr Cancer Ther 2010 Dec;9(4):348-53

Department of Behavioral Science, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77230, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1534735410387424DOI Listing
December 2010

Internal mammary lymph node recurrence: rare but characteristic metastasis site in breast cancer.

BMC Cancer 2010 Sep 7;10:479. Epub 2010 Sep 7.

Department of Medical Oncology, Cancer Hospital of Fudan University, Shanghai Medical College, Shanghai, PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-10-479DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2941505PMC
September 2010